Skip to main navigation Skip to main content Skip to footer For Medicare For Providers For Brokers For Employers Español For Individuals & Families: For Individuals & Families Medical Dental Other Supplemental Explore coverage through work How to Buy Health Insurance Types of Dental Insurance Open Enrollment vs. Special Enrollment See all topics Shop for Medicare plans Member Guide Find a Doctor Log in to myCigna
Home Knowledge Center Wellness Library asparaginase Erwinia chrysanthemi

asparaginase Erwinia chrysanthemi

Pronunciation: as PAR a jin ase er WIN ee a kri SAN the mee

Brand: Erwinase, Rylaze

What is the most important information I should know about asparaginase Erwinia chrysanthemi?

What is the most important information I should know about asparaginase Erwinia chrysanthemi?

Use only as directed. Tell your doctor if you use other medicines or have other medical conditions or allergies.

What is asparaginase Erwinia chrysanthemi?

What is asparaginase Erwinia chrysanthemi?

Asparaginase Erwinia chrysanthemi is a cancer medicine.

Erwinase is used to treat acute lymphoblastic leukemia in adults and children at least 4 months old who have become allergic to other forms of asparaginase such as Elspar, Oncaspar or Rylaze.

Rylaze is used to treat acute lymphoblastic leukemia and lymphoblastic lymphoma in adults and children at least 1 month old who have become allergic to other forms of asparaginase such as Elspar, Oncaspar or Erwinase.

Asparaginase Erwinia chrysanthemi may also be used for purposes not listed in this medication guide.

What should I discuss with my healthcare provider before using asparaginase Erwinia chrysanthemi?

What should I discuss with my healthcare provider before using asparaginase Erwinia chrysanthemi?

You should not use this medicine if you have received any form of asparaginase in the past and it caused you to have:

  • a serious allergic reaction;
  • serious pancreas problems;
  • a life-threatening blood clot; or
  • serious bleeding problems.

Tell your doctor if you have ever had:

  • problems with your liver or pancreas;
  • bleeding problems;
  • a blood clot; or
  • diabetes.

May harm an unborn baby. You may need a pregnancy test to make sure you are not pregnant. Use birth control while using this medicine and for at least 3 months after your last dose. Tell your doctor if you become pregnant.

Asparaginase Erwinia chrysanthemi can make hormonal birth control less effective, including birth control pills, injections, implants, skin patches, and vaginal rings. Use barrier birth control to prevent pregnancy: condom, diaphragm, cervical cap, or contraceptive sponge.

Do not breastfeed while using this medicine, and for at least 3 months after your last dose of Erwinase or 1 week after your last dose of Rylaze.

How should I use asparaginase Erwinia chrysanthemi?

How should I use asparaginase Erwinia chrysanthemi?

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Asparaginase Erwinia chrysanthemi is injected into a muscle or into a vein. Erwinase is usually given every 48 hours. Rylaze can be given every 48 hours or given 3 times per week.

Read and carefully follow any Instructions for Use provided with the medicine. Ask your doctor or pharmacist if you don't understand how to use an injection.

Your healthcare provider will show you where to inject asparaginase Erwinia chrysanthemi. Do not inject into the same place two times in a row.

Do not shake the medication bottle or you may ruin the medicine.

Prepare an injection only when you are ready to give it. Call your pharmacist if the medicine has changed colors or has particles in it.

Do not reuse a needle or syringe. Place them in a puncture-proof "sharps" container and dispose of it following state or local laws. Keep out of the reach of children and pets.

Your blood will need to be tested often and your dose or medication schedule may be changed based on the results.

Doses are based on body surface area (height and weight). Your dose may change if you gain or lose weight or if you are still growing.

You may be given other medications to help prevent serious side effects or allergic reaction. Keep taking these medicines for as long as your doctor has prescribed.

Throw away a vial (bottle) after one use, even if there is still medicine left inside.

Follow all storage instructions provided with asparaginase Erwinia chrysanthemi. Your pharmacist can provide more information about how to store this medicine.

What happens if I miss a dose?

What happens if I miss a dose?

Call your doctor for instructions if you miss a dose.

What happens if I overdose?

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using asparaginase Erwinia chrysanthemi?

What should I avoid while using asparaginase Erwinia chrysanthemi?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

What are the possible side effects of asparaginase Erwinia chrysanthemi?

What are the possible side effects of asparaginase Erwinia chrysanthemi?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • easy bruising or bleeding (nosebleeds, bleeding gums);
  • any bleeding that will not stop;
  • blisters or ulcers in your mouth, red or swollen gums, trouble swallowing;
  • signs of liver or pancreas problems --severe stomach pain (that may spread to your back), nausea or vomiting, jaundice (yellowing of the skin or eyes);
  • signs of a blood clot --sudden numbness or weakness (especially on one side of the body), severe headache, chest pain, feeling short of breath, pain or swelling in an arm or leg;
  • low white blood cell counts --fever, mouth sores, skin sores, sore throat, cough; or
  • high blood sugar --increased thirst, increased urination, dry mouth, fruity breath odor.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects may include:

  • liver or pancreas problems;
  • bleeding or blood clots;
  • high blood sugar;
  • stomach pain, loss of appetite, nausea, vomiting, diarrhea;
  • fever, headache, tiredness, mouth sores;
  • bone pain, muscle or joint pain;
  • allergic reaction, skin rash; or
  • abnormal liver function tests.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect asparaginase Erwinia chrysanthemi?

What other drugs will affect asparaginase Erwinia chrysanthemi?

Other drugs may affect asparaginase Erwinia chrysanthemi, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Where can I get more information?

Where can I get more information?

Your doctor or pharmacist can provide more information about asparaginase Erwinia chrysanthemi.

This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card File a claim View my claims and EOBs Check coverage under my plan See prescription drug list Find an in-network doctor, dentist, or facility Find a form Find 1095-B tax form information View the Cigna Glossary Contact Cigna

Audiences

Individuals and Families Medicare Employers Brokers Providers

Secure Member Sites

myCigna member portal Health Care Provider portal Cigna for Employers Client Resource Portal Cigna for Brokers

The Cigna Group Information

About The Cigna Group Company Profile Careers Newsroom Investors Suppliers The Cigna Group Third Party Administrators International Evernorth

 Cigna. All rights reserved.

Privacy Legal Product Disclosures Cigna Company Names Customer Rights Accessibility Non-Discrimination Notice Language Assistance [PDF] Report Fraud Sitemap Cookie Settings

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., Cigna HealthCare of Georgia, Inc., Cigna HealthCare of North Carolina, Inc., Cigna HealthCare of South Carolina, Inc., and Cigna HealthCare of Texas, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details